Gilbert Omenn

Gilbert Omenn

Directeur/Membre du Conseil chez GALECTIN THERAPEUTICS INC.

Fortune : 353 652 $ au 31/10/2026

85 ans
Commercial Services
Health Technology
Consumer Services

Profil

Dr. Gilbert S.
Omenn
is an Independent Director at Amesite, Inc., an Independent Director at Galectin Therapeutics, Inc., a Professor at University of Michigan, a Member at American Academy of Arts & Sciences, a Member at Association of American Physicians, a Member at National Academy of Medicine (United States), a Member-Community Preventive Services Task Force of Centers for Disease Control & Prevention and a Vice President at Human Proteome Organization.
He is on the Board of Directors at Amesite, Inc., Galectin Therapeutics, Inc., Armune BioScience, Inc., Life Sciences Society, MedsynBio LLCuu, Oncofusion Therapeutics, Inc., Phenomics Health, Inc., Population Services International, Salzburg Global Seminar, Inc., The Center for Public Integrity, The Hastings Center and The CNA Corp.
Dr. Omenn was previously employed as an Independent Director by Angion Biomedica Corp., a Council Member by National Academy of Medicine (United States), an Independent Director by Esperion Therapeutics, Inc., a Member-Scientific Management Review by National Institutes of Health, a Chief Executive Officer by University of Michigan Health System, a Chief Executive Officer by University of Miami Health System, an Independent Director by Amgen, Inc., a Professor by University of Washington, an Associate Director by Office of Management & Budget, an Associate Director by Office of Science & Technology Policy, a President by American Association for the Advancement of Science, a Member by American College of Physicians, Inc. /Old/, an Advisor by Arboretum Ventures LLC, a Member by Fred Hutchinson Cancer Research Center, an Affiliate Faculty by Institute for Systems Biology, and a Chairman by tranSMART Foundation.
He also served on the board at Amesite, Inc. /Old/, Etubics Corp., Trukera Medical, Rohm & Haas Co., Fred Hutchinson Cancer Research Center, Unitunited Way Foundation and US Civilian Research & Development Foundation.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/02/2026 82 240 ( 0,08% ) 273 037 $ 31/10/2026
30/09/2026 143 699 ( 2,19% ) 80 615 $ 31/10/2026

Postes actifs de Gilbert Omenn

SociétésPosteDébut
GALECTIN THERAPEUTICS INC. Directeur/Membre du Conseil 23/09/2014
AMESITE INC. Directeur/Membre du Conseil 01/03/2020
Directeur/Membre du Conseil 31/03/2009
Directeur/Membre du Conseil 18/04/2011
Directeur/Membre du Conseil 18/04/2011
Directeur/Membre du Conseil 18/04/2011
Life Sciences Society
Directeur/Membre du Conseil 18/04/2011
Directeur/Membre du Conseil 20/05/2011
Directeur/Membre du Conseil -
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Gilbert Omenn

SociétésPosteFin
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Gilbert Omenn

Formation de Gilbert Omenn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

90

Relations au 1er degré

41

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées41

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Government

Government

Commercial Services

Consumer Services

Commercial Services

Government

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Human Proteome Organization

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Miscellaneous

Commercial Services

Life Sciences Society

Health Services

Health Technology

Commercial Services

Finance

Technology Services

Technology Services

Office of Management & Budget

MedsynBio LLCuu

Finance

  1. Bourse
  2. Insiders
  3. Gilbert Omenn